{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-1978-N-0027\" sorted by posted_date descending", "rows": [["FDA-1978-N-0027-0077", "FDA", "FDA-1978-N-0027", "Skin Protectant Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment", "Notice", "Correction", "2004-08-19T04:00:00Z", 2004, 8, "2004-08-18T04:00:00Z", null, "2019-08-01T13:38:09Z", "04-18975", 0, 0, "0900006480560e47"], ["FDA-1978-N-0027-0076", "FDA", "FDA-1978-N-0027", "Petition Approval Response Letter from FDA/Office of the Commissioner to The Cosmetic, Toiletry & Fragrance Association", "Other", "Approval", "2004-02-26T05:00:00Z", 2004, 2, null, null, "2019-06-04T13:29:10Z", null, 0, 0, "0900006480560e43"], ["FDA-1978-N-0027-0075", "FDA", "FDA-1978-N-0027", "Skin Protectant Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment", "Notice", "Notice of Final Rule", "2003-12-09T05:00:00Z", 2003, 12, "2003-12-09T05:00:00Z", "2004-02-10T04:59:59Z", "2019-08-01T14:04:49Z", "03-30394", 0, 0, "0900006480560e40"], ["FDA-1978-N-0027-0074", "FDA", "FDA-1978-N-0027", "Acknowledgment Letter from FDA to Petition for Reconsideration from The Cosmetic, Toiletry & Fragrance Association", "Other", "Acknowledgement Letter/Receipt", "2003-07-10T04:00:00Z", 2003, 7, null, null, "2019-06-04T12:38:22Z", null, 0, 0, "0900006480560e32"], ["FDA-1978-N-0027-0073", "FDA", "FDA-1978-N-0027", "Acknowledgment Letter from FDA to Petition for Reconsideration from The Cosmetic, Toiletry & Fragrance Association", "Other", "Acknowledgement Letter/Receipt", "2003-07-10T04:00:00Z", 2003, 7, null, null, "2019-06-03T20:24:34Z", null, 0, 0, "0900006480560e30"], ["FDA-1978-N-0027-0069", "FDA", "FDA-1978-N-0027", "Tab I.9: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T14:55:09Z", null, 0, 0, "0900006480560df8"], ["FDA-1978-N-0027-0015", "FDA", "FDA-1978-N-0027", "Tab V.22: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:38:07Z", null, 0, 0, "0900006480560cf8"], ["FDA-1978-N-0027-0022", "FDA", "FDA-1978-N-0027", "Tab P.16: Letter from FDA to The United States Pharmacopeial Convention Inc. Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:39:02Z", null, 0, 0, "0900006480560d0d"], ["FDA-1978-N-0027-0036", "FDA", "FDA-1978-N-0027", "Tab B: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:41:02Z", null, 0, 0, "0900006480560d3f"], ["FDA-1978-N-0027-0059", "FDA", "FDA-1978-N-0027", "Tab Y: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:44:11Z", null, 0, 0, "0900006480560ddc"], ["FDA-1978-N-0027-0058", "FDA", "FDA-1978-N-0027", "Tab X: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:44:04Z", null, 0, 0, "0900006480560dae"], ["FDA-1978-N-0027-0072", "FDA", "FDA-1978-N-0027", "Skin Protectant Drug Products for Over The Counter Human Use; Final", "Notice", "Notice of Final Rule", "2003-06-13T04:00:00Z", 2003, 6, "2003-06-04T04:00:00Z", "2003-09-03T03:59:59Z", "2019-08-01T15:33:43Z", "03-13751", 0, 0, "0900006480560e22"], ["FDA-1978-N-0027-0010", "FDA", "FDA-1978-N-0027", "Tab LL.38: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:37:23Z", null, 0, 0, "0900006480560cf1"], ["FDA-1978-N-0027-0012", "FDA", "FDA-1978-N-0027", "Tab S.19: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:37:41Z", null, 0, 0, "0900006480560cf3"], ["FDA-1978-N-0027-0019", "FDA", "FDA-1978-N-0027", "Tab Z.26: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:38:35Z", null, 0, 0, "0900006480560d04"], ["FDA-1978-N-0027-0024", "FDA", "FDA-1978-N-0027", "Tab BB.28: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:39:20Z", null, 0, 0, "0900006480560d13"], ["FDA-1978-N-0027-0025", "FDA", "FDA-1978-N-0027", "Tab CC.29: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:39:28Z", null, 0, 0, "0900006480560d15"], ["FDA-1978-N-0027-0037", "FDA", "FDA-1978-N-0027", "Tab C: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:41:10Z", null, 0, 0, "0900006480560d41"], ["FDA-1978-N-0027-0040", "FDA", "FDA-1978-N-0027", "Tab F: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:41:32Z", null, 0, 0, "0900006480560d77"], ["FDA-1978-N-0027-0042", "FDA", "FDA-1978-N-0027", "Tab H: Letter from FDA to Warner Lambert Company Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:41:48Z", null, 0, 0, "0900006480560d7d"], ["FDA-1978-N-0027-0046", "FDA", "FDA-1978-N-0027", "Tab L: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:42:21Z", null, 0, 0, "0900006480560d89"], ["FDA-1978-N-0027-0023", "FDA", "FDA-1978-N-0027", "Tab Q.17: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:39:12Z", null, 0, 0, "0900006480560d10"], ["FDA-1978-N-0027-0066", "FDA", "FDA-1978-N-0027", "Tab F.6: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:45:11Z", null, 0, 0, "0900006480560def"], ["FDA-1978-N-0027-0006", "FDA", "FDA-1978-N-0027", "Tab L.12: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:36:53Z", null, 0, 0, "0900006480560ced"], ["FDA-1978-N-0027-0020", "FDA", "FDA-1978-N-0027", "Tab AA.27: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:38:43Z", null, 0, 0, "0900006480560d07"], ["FDA-1978-N-0027-0033", "FDA", "FDA-1978-N-0027", "Table of Contents Re: Skin Protectant Drug Products for Over The Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:40:38Z", null, 0, 0, "0900006480560d2b"], ["FDA-1978-N-0027-0048", "FDA", "FDA-1978-N-0027", "Tab N: Letter of Acknowledgment from FDA to Revlon Health Care Group Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Rule", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:42:36Z", null, 0, 0, "0900006480560d8f"], ["FDA-1978-N-0027-0056", "FDA", "FDA-1978-N-0027", "Tab V: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:43:48Z", null, 0, 0, "0900006480560da7"], ["FDA-1978-N-0027-0014", "FDA", "FDA-1978-N-0027", "Tab U.21: Letter from FDA to Whitehall Laboratories Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:37:58Z", null, 0, 0, "0900006480560cf5"], ["FDA-1978-N-0027-0057", "FDA", "FDA-1978-N-0027", "Tab W: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:43:56Z", null, 0, 0, "0900006480560daa"], ["FDA-1978-N-0027-0008", "FDA", "FDA-1978-N-0027", "Tab N.14: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:37:13Z", null, 0, 0, "0900006480560cef"], ["FDA-1978-N-0027-0032", "FDA", "FDA-1978-N-0027", "Tab KK.37: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:40:29Z", null, 0, 0, "0900006480560d28"], ["FDA-1978-N-0027-0035", "FDA", "FDA-1978-N-0027", "Tab A: Subject- Citizen Petition on Aveeno Products Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:40:55Z", null, 0, 0, "0900006480560d3d"], ["FDA-1978-N-0027-0039", "FDA", "FDA-1978-N-0027", "Tab E: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:41:25Z", null, 0, 0, "0900006480560d74"], ["FDA-1978-N-0027-0049", "FDA", "FDA-1978-N-0027", "Tab O: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:42:44Z", null, 0, 0, "0900006480560d91"], ["FDA-1978-N-0027-0051", "FDA", "FDA-1978-N-0027", "Tab Q: Letter from Chesebrough Ponds Inc. to FDA Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:43:07Z", null, 0, 0, "0900006480560d98"], ["FDA-1978-N-0027-0028", "FDA", "FDA-1978-N-0027", "Tab GG.33: Letter from FDA to The United States PharmaCopeial Convention Inc. Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:39:52Z", null, 0, 0, "0900006480560d1e"], ["FDA-1978-N-0027-0053", "FDA", "FDA-1978-N-0027", "Tab S: Minutes of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:43:23Z", null, 0, 0, "0900006480560da0"], ["FDA-1978-N-0027-0017", "FDA", "FDA-1978-N-0027", "Tab X.24: Letter from FDA to The United States Pharmacopeial Convention Inc. Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-05T17:23:55Z", null, 0, 0, "0900006480560cfd"], ["FDA-1978-N-0027-0052", "FDA", "FDA-1978-N-0027", "Tab R: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:43:15Z", null, 0, 0, "0900006480560d9b"], ["FDA-1978-N-0027-0021", "FDA", "FDA-1978-N-0027", "Tab O.15: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:38:51Z", null, 0, 0, "0900006480560d09"], ["FDA-1978-N-0027-0045", "FDA", "FDA-1978-N-0027", "Tab K: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:42:12Z", null, 0, 0, "0900006480560d86"], ["FDA-1978-N-0027-0055", "FDA", "FDA-1978-N-0027", "Tab U: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:43:41Z", null, 0, 0, "0900006480560da4"], ["FDA-1978-N-0027-0061", "FDA", "FDA-1978-N-0027", "Tab A.1: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:44:27Z", null, 0, 0, "0900006480560de2"], ["FDA-1978-N-0027-0067", "FDA", "FDA-1978-N-0027", "Tab G.7: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:45:20Z", null, 0, 0, "0900006480560df2"], ["FDA-1978-N-0027-0005", "FDA", "FDA-1978-N-0027", "Tab K.11: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:36:41Z", null, 0, 0, "0900006480560cec"], ["FDA-1978-N-0027-0013", "FDA", "FDA-1978-N-0027", "Tab T.20: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:37:49Z", null, 0, 0, "0900006480560cf4"], ["FDA-1978-N-0027-0031", "FDA", "FDA-1978-N-0027", "Tab JJ.36: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:40:20Z", null, 0, 0, "0900006480560d26"], ["FDA-1978-N-0027-0034", "FDA", "FDA-1978-N-0027", "Tab 1.0: Correspondence & Memoranda Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:40:46Z", null, 0, 0, "0900006480560d3a"], ["FDA-1978-N-0027-0044", "FDA", "FDA-1978-N-0027", "Tab J: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:42:04Z", null, 0, 0, "0900006480560d82"], ["FDA-1978-N-0027-0062", "FDA", "FDA-1978-N-0027", "Tab B.2: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:44:39Z", null, 0, 0, "0900006480560de5"], ["FDA-1978-N-0027-0011", "FDA", "FDA-1978-N-0027", "Tab R.18: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:37:31Z", null, 0, 0, "0900006480560cf2"], ["FDA-1978-N-0027-0016", "FDA", "FDA-1978-N-0027", "Tab W.23: Letter from FDA to Joseph Deutsch Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:38:14Z", null, 0, 0, "0900006480560cfc"], ["FDA-1978-N-0027-0026", "FDA", "FDA-1978-N-0027", "Tab EE.31: Letter from FDA to David Buddrus M.D. Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:39:36Z", null, 0, 0, "0900006480560d18"], ["FDA-1978-N-0027-0030", "FDA", "FDA-1978-N-0027", "Tab II.35: Letter from FDA to The Andrews Jergens Company Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:40:09Z", null, 0, 0, "0900006480560d23"], ["FDA-1978-N-0027-0038", "FDA", "FDA-1978-N-0027", "Tab D: Letter from FDA to Church and Dwight Co., Inc. Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:41:18Z", null, 0, 0, "0900006480560d70"], ["FDA-1978-N-0027-0071", "FDA", "FDA-1978-N-0027", "Skin Protectant Drug Products for Over The Counter Human Use; Final", "Notice", "Notice of Final Rule", "2003-06-13T04:00:00Z", 2003, 6, "2003-06-04T04:00:00Z", "2003-09-03T03:59:59Z", "2019-08-01T15:28:54Z", "03-13751", 0, 0, "0900006480560e1d"], ["FDA-1978-N-0027-0007", "FDA", "FDA-1978-N-0027", "Tab M.13:  Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:37:00Z", null, 0, 0, "0900006480560cee"], ["FDA-1978-N-0027-0018", "FDA", "FDA-1978-N-0027", "Tab Y.25: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:38:27Z", null, 0, 0, "0900006480560d01"], ["FDA-1978-N-0027-0041", "FDA", "FDA-1978-N-0027", "Tab G: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:41:41Z", null, 0, 0, "0900006480560d7a"], ["FDA-1978-N-0027-0060", "FDA", "FDA-1978-N-0027", "Tab Z: Memo Record of Lubriderm Drug Labeling Claim Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:44:19Z", null, 0, 0, "0900006480560de0"], ["FDA-1978-N-0027-0027", "FDA", "FDA-1978-N-0027", "Tab FF.32: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:39:43Z", null, 0, 0, "0900006480560d1b"], ["FDA-1978-N-0027-0047", "FDA", "FDA-1978-N-0027", "Tab M: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:42:28Z", null, 0, 0, "0900006480560d8b"], ["FDA-1978-N-0027-0050", "FDA", "FDA-1978-N-0027", "Tab P: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:43:00Z", null, 0, 0, "0900006480560d93"], ["FDA-1978-N-0027-0065", "FDA", "FDA-1978-N-0027", "Tab E.5: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:45:02Z", null, 0, 0, "0900006480560dee"], ["FDA-1978-N-0027-0068", "FDA", "FDA-1978-N-0027", "Tab H.8: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:45:28Z", null, 0, 0, "0900006480560df6"], ["FDA-1978-N-0027-0064", "FDA", "FDA-1978-N-0027", "Tab D.4: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:44:53Z", null, 0, 0, "0900006480560deb"], ["FDA-1978-N-0027-0029", "FDA", "FDA-1978-N-0027", "Tab HH.34: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:40:01Z", null, 0, 0, "0900006480560d21"], ["FDA-1978-N-0027-0043", "FDA", "FDA-1978-N-0027", "Tab I: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:41:55Z", null, 0, 0, "0900006480560d80"], ["FDA-1978-N-0027-0054", "FDA", "FDA-1978-N-0027", "Tab T: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:43:30Z", null, 0, 0, "0900006480560da1"], ["FDA-1978-N-0027-0063", "FDA", "FDA-1978-N-0027", "Tab C.3: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:44:46Z", null, 0, 0, "0900006480560de8"], ["FDA-1978-N-0027-0070", "FDA", "FDA-1978-N-0027", "Tab J.10: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-06T15:45:40Z", null, 0, 0, "0900006480560e1a"], ["FDA-1978-N-0027-0009", "FDA", "FDA-1978-N-0027", "Tab DD.30: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph", "Supporting & Related Material", "Background Material", "2003-06-13T04:00:00Z", 2003, 6, null, null, "2019-06-05T17:22:38Z", null, 0, 0, "0900006480560cf0"], ["FDA-1978-N-0027-0004", "FDA", "FDA-1978-N-0027", "Antifungal Drug Products for Over-The-Counter Human Use; External Analgesic Drug Products for Over-The-Counter Human Use; Skin Protectant Drug Products for Over-The-Counter Human Use; and Topical Antimicrobial Drug Products for Over-The-Counter Human Use; Reopening of Administrative Records", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "1997-11-21T05:00:00Z", 1997, 11, "1997-11-19T05:00:00Z", "1998-02-18T04:59:59Z", "2019-08-01T15:43:51Z", "97-30410", 0, 0, "0900006480560ce9"], ["FDA-1978-N-0027-0003", "FDA", "FDA-1978-N-0027", "Talc; Consumer Uses and Health Perspectives; Public Meetings", "Notice", "General Notice", "1994-01-31T05:00:00Z", 1994, 1, "1994-01-14T05:00:00Z", "1994-03-03T04:59:59Z", "2019-08-01T14:55:18Z", "94-1083", 0, 0, "0900006480560ccb"]], "truncated": false, "filtered_table_rows_count": 75, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-1978-N-0027"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027", "results": [{"value": "FDA", "label": "FDA", "count": 75, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1978-N-0027", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 65, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 5, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027&document_type=Notice", "selected": false}, {"value": "Other", "label": "Other", "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027&document_type=Other", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027&document_type=Proposed+Rule", "selected": false}, {"value": "Rule", "label": "Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027", "results": [{"value": 2003, "label": 2003, "count": 71, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027&posted_year=2003", "selected": false}, {"value": 2004, "label": 2004, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027&posted_year=2004", "selected": false}, {"value": 1994, "label": 1994, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027&posted_year=1994", "selected": false}, {"value": 1997, "label": 1997, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027&posted_year=1997", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027&_facet=comment_start_date"}, {"name": "comment_end_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027&_facet=comment_end_date"}, {"name": "fr_doc_num", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027&_facet=fr_doc_num"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0027&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 661.0846419353038, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}